Symposium: Integrating Chemoprevention Strategies to End Malaria
When: Wednesday 24 April 2024, 10:30-12:00 (CAT) Where: Kigali Convention Centre, Room Mezzanine Organisers: Barcelona Institute for Global Health (ISGlobal, Spain) and Centro de Investigação em Saúde de Manhiça (CISM, Mozambique)
The latest WHO guidelines for malaria control recommend the combined use of different chemoprevention strategies to prevent malaria infection and its adverse health impact. These strategies include perennial and seasonal malaria chemoprevention (PMC and SMC) for young children and intermittent preventive treatment for pregnant women (IPTp) living in moderate to high transmission areas. More recently recommended strategies are Intermittent preventive treatment in school-aged children (IPTsc) and post-discharge malaria chemoprevention (PDMC) to children admitted with severe anaemia. Despite some of these interventions being recommended for decades, their implementation and coverage remain a challenge in many sub-Saharan African countries.
This symposium will review novel findings on the efficacy and effectiveness of malaria chemoprevention strategies implemented in selected sub-Saharan countries, discuss implementation opportunities and challenges of the different strategies based on real country examples, and learn and discuss the practical implications of their scale-up combining malaria vaccines roll-out.
Optimizing malaria control in pregnancy: latest evidence from clinical trials to implementation science Raquel González, ISGlobal (Spain)
Implementing PMC in SSA: lessons learned from Sierra Leone national scale-up Augustin Fombah, ISGlobal (Spain)
Malaria control and elimination chemoprevention strategies in Mozambique: from SMC to Massive Drug Administration implementation Pedro Aide, CISM (Mozambique)
Approaches to malaria chemoprevention in school-age children: IPTsc and extending the age of SMC Lauren Cohee, Liverpool School of Tropical Medicine (UK)
Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali Jean-Bosco Ouedraogo, Institut de Recherche en Sciences de la Sante (Burkina Faso)
We use cookies on our website to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Accept All," you consent to the use of all cookies. However, you may visit "Cookie Settings" to provide controlled consent.